Therapeutic Solutions International Inc (TSOI)

[centsability4me]

TSI is a conglomerate

- a parent company w/ 3 subsidiaries , and a nutraceutical division

http://therapeuticsolutionsint.com/

TSI has 12 patents in the pipeline ,w/ 1 granted , and 3 published .


https://www.google.com/patents/US9682047 (granted)

https://www.google.com/patents/US20170020930 (published)

https://www.google.com/patents/US20170143812 (published)

https://www.google.com/patents/US20170087344 (published)

TSOI filings are up to date w/ the SEC and is fully reporting now . The possibility of a RS was cancelled w/ yesterday's quarterly filing .

https://www.sec.gov/Archives/edgar/data/1419051/0001/07878217001307/f8k092617_8k.htm

Re:TSI subsidiaries and what they are doing :

OMNI - a new niche market in fetal/maternal health .

OmniBiome, Inc. is the world’s first company focused on therapeutic / Rx approaches to either utilize or intervene with the systemic effects of the vaginal, lactal-duct and oral microbiomes for improving maternal healthcare and resulting birth outcomes.

The Company will focus initially on developing CLIA Dx services for both pre-pregnancy-associated and pregnancy-associated conditions or diseases where there is a substantive link with microbiome dysbiosis (disruption or imbalance), as well as on restoring eubiosis (proper balance).

In parallel OmniBiome will build a database of aggregated patient data that will later inform development of Rx / therapeutic and medical device & drug-device combination approaches for treating the same conditions or diseases.


http://omnibiomeinc.com/


EMVOLIO - fighting cancer w/ nutraceutical involvement - a fresh approach - immuno-oncology.

Cancer compromises the immune system at different levels. A cancer treatment must therefore attack cancer at different levels.
Emvolio is developing products that can be used together to attack cancer at different levels, as well as to be used alone or in combination with existing therapies.

http://emvolio.com/

SANDBOX Dental Labs - developed , filed , and soon to be manufactured and marketed - Morpheus - sleep apnea device - no more wearing a bulky CPAP to bed each night , and the Morpheus has an adjustablity factor.
The Morpheus™ has up to 9mm of adjustable protrusion compared to TAP® at 6mm and MDSA® at 5mm. Additional titration increases the ease in which ideal positioning can be obtained without lab procedures and interrupted care. Patient or dentist can make adjustments.

http://sandbox.dental/

Re: Nutraceutical division - how many companies have patents on nutraceuticals ?

TSI has been producing very high quality nutraceuticals. Its flagship product, Projuvenol®, is a Patented (No. 9,682,047) proprietary mixture containing pterostilbene – one of the most potent antioxidants known.

http://projuvenol.com/

http://therapeuticsolutionsint.com/

TSI on Facebook :

https://www.facebook.com/tsoihome/